UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework

Jull, J; Whitehead, M; Petticrew, M; Kristjansson, E; Gough, D; Petkovic, J; Volmink, J; ... Welch, V; + view all (2017) When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework. BMJ Open , 7 (9) , Article e015815. 10.1136/bmjopen-2016-015815. Green open access

e015815.full.pdf - ["content_typename_Published version" not defined]

Download (1MB) | Preview


BACKGROUND: Randomised controlled trials can provide evidence relevant to assessing the equity impact of an intervention, but such information is often poorly reported. We describe a conceptual framework to identify health equity-relevant randomised trials with the aim of improving the design and reporting of such trials. METHODS: An interdisciplinary and international research team engaged in an iterative consensus building process to develop and refine the conceptual framework via face-to-face meetings, teleconferences and email correspondence, including findings from a validation exercise whereby two independent reviewers used the emerging framework to classify a sample of randomised trials. RESULTS: A randomised trial can usefully be classified as ‘health equity relevant’ if it assesses the effects of an intervention on the health or its determinants of either individuals or a population who experience ill health due to disadvantage defined across one or more social determinants of health. Health equity-relevant randomised trials can either exclusively focus on a single population or collect data potentially useful for assessing differential effects of the intervention across multiple populations experiencing different levels or types of social disadvantage. Trials that are not classified as ‘health equity relevant’ may nevertheless provide information that is indirectly relevant to assessing equity impact, including information about individual level variation unrelated to social disadvantage and potentially useful in secondary modelling studies. CONCLUSION: The conceptual framework may be used to design and report randomised trials. The framework could also be used for other study designs to contribute to the evidence base for improved health equity.

Type: Article
Title: When is a randomised controlled trial health equity relevant? Development and validation of a conceptual framework
Open access status: An open access version is available from UCL Discovery
DOI: 10.1136/bmjopen-2016-015815
Publisher version: http://dx.doi.org/10.1136/bmjopen-2016-015815
Language: English
Additional information: © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Keywords: Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, PUBLIC-HEALTH, INEQUALITIES, PROTOCOL
URI: http://discovery.ucl.ac.uk/id/eprint/10039507
Downloads since deposit
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item